Call us for quotes at (610) 458-1112 or 
Email us at primbiobiz@primbioresearch.com
PRIMBIO
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • COVID-19 RT-PCR TEST
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • COVID-19 RT-PCR TEST
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote

PRIMBIo Colorectal cancer panel

Colorectal Cancers are cancers that begin in the large intestine or rectum.  Research has identified numerous germline and somatic mutations in 48 genes that are linked to cancers  of the colon and rectum. Next Generation Sequencing (NGS) makes it possible to test the entire exonic regions of all 48 genes.   The PrimBio hereditary CRC panel examines germline mutations in genes that may predispose patients to colorectal cancer.  This panel covers genes associated with all forms of hereditary colorectal cancer and can help patients and physicians determine if further intervention or action is required based on their results.  If detected early, the probability of patient mortality due to the disease is greatly reduced.

​​
molecular Diagnostic
requisition form
Hereditary Test
​Questionnaire
SAMPLE SUBMISSION
​ GUIDELINES
Powered by Create your own unique website with customizable templates.